Matrix metalloproteinase-3 removes agrin from synaptic basal lamina

Michael Vansaun, Michael J. Werle

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Agrin, a heparin sulfate proteoglycan, is an integral member of the synaptic basal lamina and plays a critical role in the formation and maintenance of the neuromuscular junction. The N-terminal region of agrin binds tightly to basal lamina, while the C-terminal region interacts with a muscle-specific tyrosine kinase (MuSK) to induce the formation of the postsynaptic apparatus. Although the binding of agrin to basal lamina is tight, the binding of agrin to MuSK has yet to be shown; therefore, basal lamina binding is critical for maintaining the presentation of agrin to MuSK. Here we report evidence that supports our hypothesis that matrix metalloproteinase-3 (MMP-3) is responsible for the removal of agrin from synaptic basal lamina. Antibodies to the hinge region of human MMP-3 recognize molecules concentrated at the frog neuromuscular junction in both cross sections and whole mounts. Electron microscopy of neuromuscular junctions stained with antibodies to MMP-3 reveals that staining is found in the extracellular matrix surrounding the Schwann cell. Treatment of sections from frog anterior tibialis muscle with MMP-3 results in a clear and reproducible removal of agrin immunoreactivity from synaptic basal lamina. The same MMP-3 treatment does not alter anti-laminin staining. These results support our hypothesis that synaptic activity results in the activation of MMP-3 at the neuromuscular junction and that MMP-3 specifically removes agrin from synaptic basal lamina. (C) 2000 John Wiley and Sons, Inc.

Original languageEnglish (US)
Pages (from-to)140-149
Number of pages10
JournalJournal of Neurobiology
Volume43
Issue number2
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Agrin
Matrix Metalloproteinase 3
Basement Membrane
Neuromuscular Junction
Protein-Tyrosine Kinases
Muscles
Anura
Staining and Labeling
Antibodies
Schwann Cells
Laminin
Extracellular Matrix
Electron Microscopy
Maintenance

Keywords

  • Agrin
  • Matrix metalloproteinase-3
  • Neuromuscular junction
  • Schwann cell
  • Synapse elimination

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Matrix metalloproteinase-3 removes agrin from synaptic basal lamina. / Vansaun, Michael; Werle, Michael J.

In: Journal of Neurobiology, Vol. 43, No. 2, 2000, p. 140-149.

Research output: Contribution to journalArticle

@article{890aea0528de4afa83ccbc571dc5ba93,
title = "Matrix metalloproteinase-3 removes agrin from synaptic basal lamina",
abstract = "Agrin, a heparin sulfate proteoglycan, is an integral member of the synaptic basal lamina and plays a critical role in the formation and maintenance of the neuromuscular junction. The N-terminal region of agrin binds tightly to basal lamina, while the C-terminal region interacts with a muscle-specific tyrosine kinase (MuSK) to induce the formation of the postsynaptic apparatus. Although the binding of agrin to basal lamina is tight, the binding of agrin to MuSK has yet to be shown; therefore, basal lamina binding is critical for maintaining the presentation of agrin to MuSK. Here we report evidence that supports our hypothesis that matrix metalloproteinase-3 (MMP-3) is responsible for the removal of agrin from synaptic basal lamina. Antibodies to the hinge region of human MMP-3 recognize molecules concentrated at the frog neuromuscular junction in both cross sections and whole mounts. Electron microscopy of neuromuscular junctions stained with antibodies to MMP-3 reveals that staining is found in the extracellular matrix surrounding the Schwann cell. Treatment of sections from frog anterior tibialis muscle with MMP-3 results in a clear and reproducible removal of agrin immunoreactivity from synaptic basal lamina. The same MMP-3 treatment does not alter anti-laminin staining. These results support our hypothesis that synaptic activity results in the activation of MMP-3 at the neuromuscular junction and that MMP-3 specifically removes agrin from synaptic basal lamina. (C) 2000 John Wiley and Sons, Inc.",
keywords = "Agrin, Matrix metalloproteinase-3, Neuromuscular junction, Schwann cell, Synapse elimination",
author = "Michael Vansaun and Werle, {Michael J.}",
year = "2000",
doi = "10.1002/(SICI)1097-4695(200005)43:2<140::AID-NEU4>3.0.CO;2-K",
language = "English (US)",
volume = "43",
pages = "140--149",
journal = "Developmental Neurobiology",
issn = "0022-3034",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Matrix metalloproteinase-3 removes agrin from synaptic basal lamina

AU - Vansaun, Michael

AU - Werle, Michael J.

PY - 2000

Y1 - 2000

N2 - Agrin, a heparin sulfate proteoglycan, is an integral member of the synaptic basal lamina and plays a critical role in the formation and maintenance of the neuromuscular junction. The N-terminal region of agrin binds tightly to basal lamina, while the C-terminal region interacts with a muscle-specific tyrosine kinase (MuSK) to induce the formation of the postsynaptic apparatus. Although the binding of agrin to basal lamina is tight, the binding of agrin to MuSK has yet to be shown; therefore, basal lamina binding is critical for maintaining the presentation of agrin to MuSK. Here we report evidence that supports our hypothesis that matrix metalloproteinase-3 (MMP-3) is responsible for the removal of agrin from synaptic basal lamina. Antibodies to the hinge region of human MMP-3 recognize molecules concentrated at the frog neuromuscular junction in both cross sections and whole mounts. Electron microscopy of neuromuscular junctions stained with antibodies to MMP-3 reveals that staining is found in the extracellular matrix surrounding the Schwann cell. Treatment of sections from frog anterior tibialis muscle with MMP-3 results in a clear and reproducible removal of agrin immunoreactivity from synaptic basal lamina. The same MMP-3 treatment does not alter anti-laminin staining. These results support our hypothesis that synaptic activity results in the activation of MMP-3 at the neuromuscular junction and that MMP-3 specifically removes agrin from synaptic basal lamina. (C) 2000 John Wiley and Sons, Inc.

AB - Agrin, a heparin sulfate proteoglycan, is an integral member of the synaptic basal lamina and plays a critical role in the formation and maintenance of the neuromuscular junction. The N-terminal region of agrin binds tightly to basal lamina, while the C-terminal region interacts with a muscle-specific tyrosine kinase (MuSK) to induce the formation of the postsynaptic apparatus. Although the binding of agrin to basal lamina is tight, the binding of agrin to MuSK has yet to be shown; therefore, basal lamina binding is critical for maintaining the presentation of agrin to MuSK. Here we report evidence that supports our hypothesis that matrix metalloproteinase-3 (MMP-3) is responsible for the removal of agrin from synaptic basal lamina. Antibodies to the hinge region of human MMP-3 recognize molecules concentrated at the frog neuromuscular junction in both cross sections and whole mounts. Electron microscopy of neuromuscular junctions stained with antibodies to MMP-3 reveals that staining is found in the extracellular matrix surrounding the Schwann cell. Treatment of sections from frog anterior tibialis muscle with MMP-3 results in a clear and reproducible removal of agrin immunoreactivity from synaptic basal lamina. The same MMP-3 treatment does not alter anti-laminin staining. These results support our hypothesis that synaptic activity results in the activation of MMP-3 at the neuromuscular junction and that MMP-3 specifically removes agrin from synaptic basal lamina. (C) 2000 John Wiley and Sons, Inc.

KW - Agrin

KW - Matrix metalloproteinase-3

KW - Neuromuscular junction

KW - Schwann cell

KW - Synapse elimination

UR - http://www.scopus.com/inward/record.url?scp=0034091912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034091912&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4695(200005)43:2<140::AID-NEU4>3.0.CO;2-K

DO - 10.1002/(SICI)1097-4695(200005)43:2<140::AID-NEU4>3.0.CO;2-K

M3 - Article

C2 - 10770843

AN - SCOPUS:0034091912

VL - 43

SP - 140

EP - 149

JO - Developmental Neurobiology

JF - Developmental Neurobiology

SN - 0022-3034

IS - 2

ER -